V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330012235 | 330004032 | 1.62 | 66.8 | null | 2014-10-23 | 2014-10-25 | OST Euramos 1 Closed Trial - A | N | N | 330008298 | DOXORUBICIN |
| 330012236 | 330010448 | 0 | null | null | 2016-08-31 | 2017-03-02 | DOXORUBICIN | N | N | 330008309 | DOXORUBICIN |
| 330012237 | 330004043 | 1.68 | 60 | Curative (C) | 2017-09-04 | 2017-11-01 | Docetaxel + Gemcitabine with GCSF | 2 | N | 330008370 | DOCETAXEL + GEMCITABINE |
| 330012238 | 330004050 | 1.7 | 71.8 | Neo-adjuvant (N) | null | 2017-01-07 | CISPLATIN + FLUOROURACIL | N | N | 330008382 | CISPLATIN + FLUOROURACIL |
| 330012239 | 330004055 | null | 95.9 | Adjuvant (A) | 2018-04-03 | 2018-04-11 | Carboplatin AUC 6 - 10 | N | N | 330008390 | CARBOPLATIN |
| 330012240 | 330004056 | 1.72 | 71.9 | Neo-adjuvant (N) | 2015-12-25 | 2015-12-25 | Etoposide + Ifosfamide (3 days) | N | N | 330008395 | ETOPOSIDE + IFOSFAMIDE |
| 330012242 | 330004072 | 1.64 | 55.1 | Curative (C) | 2018-06-01 | 2018-06-08 | Methotrexate High Dose (3g/m2) | 2 | N | 330008566 | METHOTREXATE HIGH DOSE |
| 330012243 | 330004075 | 1.78 | 57.7 | Curative (C) | 2016-07-29 | 2016-08-19 | OST Euramos 1 Closed Trial - M | Y | N | 330008567 | METHOTREXATE HIGH DOSE |
| 330012244 | 330004082 | 1.8 | 82.4 | Palliative (P) | 2015-09-10 | 2015-09-17 | Cisplatin +Fluorouracil (3 wk) | Y | Y | 330008614 | CISPLATIN + FLUOROURACIL |
| 330012245 | 330010463 | 0 | 76 | Neo-adjuvant (N) | null | 2016-07-04 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | 330008733 | MAP |
| 330012246 | 330004095 | 1.55 | 42 | Curative (C) | 2018-02-04 | 2018-02-08 | OST Euramos 1 Closed Trial - M | N | null | 330008810 | METHOTREXATE HIGH DOSE |
| 330012247 | 330004106 | 1.53 | 71.9 | Curative (C) | 2016-10-28 | 2016-11-03 | Methotrexate High Dose (3g/m2) | N | Y | 330008905 | METHOTREXATE HIGH DOSE |
| 330012249 | 330004117 | 1.64 | 68.2 | Palliative (P) | 2017-11-21 | 2017-11-21 | Etoposide + Ifosfamide (5 days) | 2 | N | 330008951 | ETOPOSIDE + IFOSFAMIDE |
| 330012250 | 330004120 | 1.55 | 44.2 | Palliative (P) | null | 2018-01-24 | CISPLATIN + FLUOROURACIL | Y | N | 330008953 | CISPLATIN + FLUOROURACIL |
| 330012251 | 330004123 | 1.66 | 54.1 | Palliative (P) | null | 2018-07-19 | Docetaxel+Gemcitabine (no prior RT) | null | null | 330008977 | DOCETAXEL + GEMCITABINE |
| 330012252 | 330004126 | null | 60.3 | Curative (C) | 2017-02-20 | 2017-03-06 | Carboplatin AUC 6 - 10 | N | Y | 330008992 | CARBOPLATIN |
| 330012253 | 330004130 | 1.87 | 69 | Neo-adjuvant (N) | 2014-10-29 | 2014-12-02 | Etoposide + Ifosfamide (5 days) | N | N | 330009031 | ETOPOSIDE + IFOSFAMIDE |
| 330012254 | 330004134 | 1.8 | 86.8 | Adjuvant (A) | 2016-06-12 | 2016-07-24 | Carboplatin AUC 2 - 5 | N | N | 330009044 | CARBOPLATIN |
| 330012256 | 330004143 | 1.9 | 151 | Palliative (P) | 2015-04-25 | 2015-06-08 | Cetuximab 7 day (>Cycle 2) | N | N | 330009101 | CETUXIMAB |
| 330012257 | 330004153 | null | null | Curative (C) | 2018-10-20 | 2018-11-29 | CETUXIMAB | N | N | 330009160 | CETUXIMAB |
| 330012258 | 330004160 | 1.7 | 101 | Curative (C) | 2017-06-23 | 2017-07-04 | MAP | Y | N | 330009184 | MAP |
| 330012259 | 330008279 | 1.73 | 75.9 | Palliative (P) | null | 2013-11-13 | DOCETAXEL + GEMCITABINE | null | null | 330009223 | DOCETAXEL + GEMCITABINE |
| 330012260 | 330004171 | 1.57 | 38.6 | Neo-adjuvant (N) | 2013-05-02 | 2013-06-07 | Methotrexate High Dose (3g/m2) | N | N | 330009253 | METHOTREXATE HIGH DOSE |
| 330012263 | 330011722 | 1.85 | 87.8 | Neo-adjuvant (N) | 2015-07-25 | 2015-07-25 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 330009445 | CISPLATIN + FLUOROURACIL |
| 330012264 | 330004207 | 1.74 | 57.3 | Palliative (P) | 2018-03-11 | 2018-05-05 | OST Euramos 1 Closed Trial - M | 02 | null | 330009744 | METHOTREXATE HIGH DOSE |
| 330012265 | 330008302 | 0 | 64.5 | Palliative (P) | 2017-09-21 | 2018-02-22 | Docetaxel + Gemcitabine (prior RT) | 02 | null | 330009753 | DOCETAXEL + GEMCITABINE |
| 330012266 | 330004216 | 1.76 | 78 | Curative (C) | 2015-10-08 | 2015-10-08 | Rituximab | N | N | 330009847 | RITUXIMAB |
| 330012267 | 330004220 | 1.84 | 68 | Neo-adjuvant (N) | 2017-08-20 | 2018-04-17 | PAM x 2 post-surgery (cycles 3&4) | N | N | 330010223 | MAP |
| 330012268 | 330004226 | null | 50.8 | Adjuvant (A) | 2016-06-06 | 2016-06-06 | CISPLATIN + FLUOROURACIL | null | null | 330010479 | CISPLATIN + FLUOROURACIL |
| 330012269 | 330004228 | 1.73 | 96.7 | Palliative (P) | 2018-06-10 | 2018-06-17 | Cisplatin +Fluorouracil (3 wk) | null | null | 330010484 | CISPLATIN + FLUOROURACIL |
| 330012271 | 330010511 | 1.91 | 64.5 | Curative (C) | 2017-01-08 | 2017-03-05 | Etoposide + Ifosfamide (3 days) | 99 | null | 330010672 | ETOPOSIDE + IFOSFAMIDE |
| 330012272 | 330004248 | 1.64 | null | Adjuvant (A) | 2014-08-23 | 2014-09-17 | PAM x 2 post-surgery (cycles 3&4) | 02 | null | 330010701 | MAP |
| 330012273 | 330004251 | 1.61 | 62.6 | Neo-adjuvant (N) | 2014-11-23 | 2015-06-19 | CISPLATIN + FLUOROURACIL | null | null | 330010712 | CISPLATIN + FLUOROURACIL |
| 330012274 | 330008328 | 0 | 63.8 | Curative (C) | 2017-09-06 | 2017-09-07 | Docetaxel + Gemcitabine with GCSF | 2 | N | 330010739 | DOCETAXEL + GEMCITABINE |
| 330012275 | 330008328 | 0 | 63.4 | Curative (C) | 2018-08-11 | 2018-09-04 | CETUXIMAB | null | null | 330010739 | CETUXIMAB |
| 330012276 | 330004261 | 1.78 | 67.5 | Curative (C) | 2017-04-09 | 2017-07-30 | Cetuximab 7 day (>Cycle 2) | N | N | 330010836 | CETUXIMAB |
| 330012277 | 330013033 | null | 65.4 | Palliative (P) | 2016-05-17 | 2016-05-17 | ETOPOSIDE + IFOSFAMIDE | Y | N | 330010873 | ETOPOSIDE + IFOSFAMIDE |
| 330012278 | 330004267 | 1.57 | 76 | Palliative (P) | 2018-06-01 | 2018-06-16 | Cetuximab 7 day (Cycle 1) | 02 | Y | 330010883 | CETUXIMAB |
| 330012279 | 330004271 | 1.67 | 66.9 | Palliative (P) | 2017-12-18 | 2017-12-27 | Docetaxel + Gemcitabine (prior RT) | 2 | N | 330010902 | DOCETAXEL + GEMCITABINE |
| 330012280 | 330004277 | 1.86 | 63.1 | Palliative (P) | 2016-12-29 | 2018-09-01 | MAP | N | N | 330010929 | MAP |
| 330012281 | 330010523 | 1.7 | 66 | Curative (C) | 2016-12-29 | 2016-12-29 | OST Euramos 1 Closed Trial - M | 02 | null | 330010974 | METHOTREXATE HIGH DOSE |
| 330012282 | 330004289 | 1.65 | 65 | Palliative (P) | 2018-03-12 | 2018-03-12 | Rituximab | 2 | N | 330010979 | RITUXIMAB |
| 330012283 | 330004291 | 1.82 | null | Palliative (P) | 2017-12-31 | 2017-12-31 | ETOPOSIDE + IFOSFAMIDE | 02 | N | 330011005 | ETOPOSIDE + IFOSFAMIDE |
| 330012284 | 330004291 | null | 60 | Adjuvant (A) | 2016-06-28 | 2016-06-30 | MAP | N | N | 330011005 | MAP |
| 330012285 | 330008347 | 0 | null | Adjuvant (A) | 2018-01-11 | 2018-01-11 | Docetaxel + Gemcitabine with GCSF | null | null | 330011029 | DOCETAXEL + GEMCITABINE |
| 330012286 | 330004302 | null | null | null | 2013-08-28 | 2013-08-28 | OST Euramos 1 Closed Trial - M | N | N | 330011097 | METHOTREXATE HIGH DOSE |
| 330012287 | 330004307 | null | 65 | Palliative (P) | 2018-01-10 | 2018-01-10 | Docetaxel + Gemcitabine (prior RT) | N | N | 330011197 | DOCETAXEL + GEMCITABINE |
| 330012288 | 330004316 | 1.73 | 91.85 | Palliative (P) | 2017-07-28 | 2017-08-11 | DOCETAXEL + GEMCITABINE | N | N | 330011267 | DOCETAXEL + GEMCITABINE |
| 330012290 | 330004327 | null | 89.9 | Curative (C) | 2016-07-08 | 2016-08-19 | OST Euramos 1 Closed Trial - M | null | N | 330011340 | METHOTREXATE HIGH DOSE |
| 330012291 | 330008367 | 1.68 | 46.4 | Curative (C) | 2018-06-24 | 2018-06-24 | OST Euramos 1 Closed Trial - M | N | N | 330011441 | METHOTREXATE HIGH DOSE |